BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹17 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of BAL PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹13 Cr |
How is Contingent Liabilities of BAL PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 0.83 | |
| Mar2024 | ₹17 Cr | 3.16 | |
| Mar2023 | ₹16 Cr | 1.18 | |
| Mar2022 | ₹16 Cr | 25.01 | |
| Mar2021 | ₹13 Cr | - | |
Compare Contingent Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹116.5 Cr | -2.1% | -4.9% | -40% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -2.1% |
-4.9% |
-40% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses